Clinical Trial Update: Rituximab in the Treatment of Graves' Disease [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reports on the use of Rituximab for Graves' disease and thyroid-associated ophthalmopathy in Phase 1/Phase 2 studies, with completed statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Disease
• Thyroid-associated Ophthalmopathy

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Odense University Hospital | Conditions: Graves´ Disease, Thyroid Associated Ophthalmopathy | Phase 1, Phase 2 | Status: COMPLETED